Poly (sebacic anhydride)

used as a growth inhibitor to selectively modify habit of griseofulvin crystals formed via the Precipitation with a compressed-fluid antisolvent (PCA) process

Also Known As:

PSA compound; polysebacic anhydride

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Anhydrides: 241
  - Poly (sebacic anhydride): 2
Lipids: 114793
- Fatty Acids: 27405
  - Decanoic Acids: 5
    - Poly (sebacic anhydride): 2

Experts

1.	Chen, Zhong: 1 article (03/2017)
2.	Cui, Yaru: 1 article (03/2017)
3.	Duan, Huaqing: 1 article (03/2017)
4.	Feng, Yulin: 1 article (03/2017)
5.	Han, Li: 1 article (03/2017)
6.	Tong, Xiaohang: 1 article (03/2017)
7.	Yang, Shilin: 1 article (03/2017)
8.	Zhu, Yongming: 1 article (03/2017)
9.	Chen, Liaobin: 1 article (11/2007)
10.	Chen, Man: 1 article (11/2007)

Related Diseases

1.	Osteomyelitis 11/01/2007 - "We developed a local drug-release system consisting of two biodegradable polymers, poly(sebacic anhydride) (PSA) and poly-D,L-lactide (PLA), for the treatment of chronic osteomyelitis. "
2.	Lung Neoplasms (Lung Cancer) 03/31/2017 - "Compared with PSA, compound 22 showed a better balance between haemolytic toxicity (HD50 > 500 μM) and cytotoxicity toward lung cancer cells A549 (IC50 = 4.68 μM). "

Related Drugs and Biologics

1.	Polymers
2.	poly(lactide) (polylactic acid)